MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202647071625 A) filed by Legend Biotech Usa Inc.; and Legend Biotech Ireland Limited on June 09, 2026, for Gprc5d-Binding Moieties, Chimeric Antigen Receptors And Uses Thereof.
Inventors include Tu, Xiaojie; Nie, Baoming; Yang, Shuai; Hao, Jiaying; Li, Hui; Ge, Chengming; and Yu, Dawei.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: It relates to GPRC5D-binding moieties, chimeric antigen receptors (CARs) having these GPRC5D-binding moieties and uses thereof. It also relates to genetically modified immune cells having a chimeric antigen receptor for use in adoptive cell therapy for treating GPRC5D-expressing cancers or tumors in a subject in need thereof.
Disclaimer: Curated by HT Syndication.
